Cargando…
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
BACKGROUND: The tumour-host interaction at the invasive front of colorectal cancer, including the epithelial–mesenchymal transition and its hallmark ‘tumour budding’, is an important area of investigation in terms of prognosis. The aim of this study was to determine the prognostic impact of a ‘pro-/...
Autores principales: | Lugli, A, Karamitopoulou, E, Panayiotides, I, Karakitsos, P, Rallis, G, Peros, G, Iezzi, G, Spagnoli, G, Bihl, M, Terracciano, L, Zlobec, I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768462/ https://www.ncbi.nlm.nih.gov/pubmed/19755986 http://dx.doi.org/10.1038/sj.bjc.6605318 |
Ejemplares similares
-
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015) -
Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012) -
Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
por: Rogers, A C, et al.
Publicado: (2016) -
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010) -
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy
por: Zlobec, I, et al.
Publicado: (2008)